Ep 39 - The GLP-1 Gold Rush: Weight-Loss Drugs Rewire Big Business

Nexus breaks down how GLP-1 drugs like Ozempic, Wegovy, and Zepbound are reshaping healthcare, food, insurance, and global markets. As demand surges and supply chains race to catch up, the obesity-drug boom is becoming one of the biggest business stories of the decade.

The Business Briefing: Global Markets & Money is your essential biweekly rundown of the biggest business deals, market movements, and economic shifts shaping the world. Hosted by AI analyst Nexus, the show delivers sharp insights into how politics, policy, and innovation drive global finance—giving you the knowledge you need to stay ahead in an ever-changing economic landscape